Terminology Service < Semantic Lookup Platform

All terms in EFO

Label	Id	Description
ubiquitin+1, truncated mutation for UBB measurement	EFO_0020844	[The determination of the amount of ubiquitin+1, truncated mutation for UBB in a sample]
vacuolar protein sorting-associated protein VTA1 homolog measurement	EFO_0020845	[The determination of the amount of vacuolar protein sorting-associated protein VTA1 homolog in a sample]
ubiquitin-conjugating enzyme E2 L3 measurement	EFO_0020840	[The determination of the amount of ubiquitin-conjugating enzyme E2 L3 in a sample]
ubiquitin-conjugating enzyme E2 N measurement	EFO_0020841	[The determination of the amount of ubiquitin-conjugating enzyme E2 N in a sample]
obsolete_qualitative or quantitative defects of myotubularin	Orphanet_207110
Glycosuria	HP_0003076	[An increased concentration of glucose in the urine.]
Hypercalcemia	HP_0003072	[An abnormally increased calcium concentration in the blood.]
Hyperglycemia	HP_0003074	[An increased concentration of glucose in the blood.]
Abnormal blood glucose concentration	HP_0011015	[An abnormality of the concentration of glucose in the blood.]
Hypoalbuminemia	HP_0003073	[Reduction in the concentration of albumin in the blood.]
obsolete_qualitative or quantitative defects of TRIM32	Orphanet_207107
response to escitalopram	EFO_0007871	[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a escitalopram stimulus. Escitalopram is the (S)-stereoisomer (Left-enantiomer) of the earlier Lundbeck drug citalopram, hence the name escitalopram. Whether escitalopram exhibits superior therapeutic properties to citalopram or merely represents an example of "evergreening" is controversial.]
response to selective serotonin reuptake inhibitor	EFO_0005658	[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a selective serotonin reuptake inhibitor stimulus, a mood-stimulating drug.]
response to norepinephrine-dopamine reuptake inhibitor	EFO_0007870	[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a norepinephrine-dopamine reuptake inhibitor stimulus. Norepinephrine–dopamine reuptake inhibitors (NDRI) are a class of drugs that act as a reuptake inhibitor for the neurotransmitters norepinephrine and dopamine by blocking the action of the norepinephrine transporter (NET) and the dopamine transporter (DAT), respectively. This in turn leads to increased extracellular concentrations of both norepinephrine and dopamine and, therefore, an increase in adrenergic and dopaminergic neurotransmission.]
ubiquitin measurement	EFO_0020839	[The determination of the amount of ubiquitin in a sample]
atmosphere unit	EFO_0005212	[The standard atmosphere is an international reference pressure defined as 101325 Pa and formerly used as a unit of pressure.]
pressure unit	UO_0000109	[A unit which is a standard measure of the force applied to a given area.]
excessive daytime sleepiness measurement	EFO_0007875	[quantification of excessive daytime sleepiness such as how often it occurs and its severity]
gut microbiome measurement	EFO_0007874	[quantification of some aspect of an individual's micrbiome of the gut]
central corneal thickness	EFO_0005213	[A measure of the corneal thickness (CCT). This can be measured by contact e.g. ultrasound, confocal microscpy or non contact methods e.g. biometry. Reduced central corneal thickness is used as an indicator for glaucoma.]